| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |